Clinical samples of PCa have revealed three highly methylated sites (H3K9me3, MBD2, and MeCP2) in the Nrf2 promoter region, which inhibits Nrf2 transcription and downregulates PCa cells [73]. The gene discussed is NFE2L2; the disease is posterior cortical atrophy.